HeartBeam, Inc. (BEAT) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, HeartBeam reported revenue of $0. Net income was -$21.0M, or -$0.62 per diluted share. Operating activities generated -$14.0M of cash, leaving -$14.6M of free cash flow. At fiscal year end, HeartBeam held $5.8M in total assets against $3.2M in total liabilities, including $4.4M of cash and equivalents.
Open the full interactive HeartBeam financials → Quarterly statements, key ratios, valuation history and price charts.
HeartBeam Key Stats
| Share Price | $0.40 |
|---|---|
| Market Cap | $21.2M |
| 52-Week Range | $0.36 – $3.44 |
| Shares Outstanding | 52.8 million (basic, 2026 Q2) |
HeartBeam Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$2.3M | -$13.0M | -$15.3M | -$19.9M | -$21.1M |
| Pre-Tax Income | -$4.4M | -$13.0M | -$14.6M | -$19.4M | -$21.0M |
| Income Tax | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$4.4M | -$13.0M | -$14.6M | -$19.4M | -$21.0M |
| Diluted EPS | -$1.03 | -$1.59 | -$0.72 | -$0.73 | -$0.62 |
HeartBeam Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$5.3M | -$5.3M | -$4.7M | -$5.0M |
| Diluted EPS | -$0.15 | -$0.16 | -$0.12 | -$0.10 |
HeartBeam Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | — | $3.6M | $16.2M | $2.4M | $4.4M |
| Current Assets | — | — | $16.8M | $2.8M | $4.7M |
| Total Assets | $14.0M | $4.0M | $17.1M | $3.3M | $5.8M |
| Total Liabilities | $588,000 | $1.7M | $1.2M | $1.6M | $3.2M |
| Shareholders' Equity | $13.4M | $2.4M | $15.9M | $1.7M | $2.6M |
HeartBeam Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash From Operations | -$3.2M | -$9.9M | -$12.1M | -$14.5M | -$14.0M |
| Cash From Investing | — | — | -$256,000 | -$201,000 | -$600,000 |
| Cash From Financing | $16.4M | $350,000 | $25.0M | $866,000 | $16.6M |
| Free Cash Flow | — | — | -$12.3M | -$14.7M | -$14.6M |
Figures from HeartBeam's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full HeartBeam financials page for every line item.
HeartBeam Company Profile
| Ticker | BEAT |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Santa Clara, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001779372 |
Frequently Asked Questions
What was HeartBeam's revenue in fiscal 2025?
HeartBeam (BEAT) reported revenue of $0 for fiscal 2025.
What is HeartBeam's annual revenue history?
HeartBeam's annual revenue by fiscal year: 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $0.
What was HeartBeam's net income in fiscal 2025?
HeartBeam reported net income of -$21.0M for fiscal 2025.
What was HeartBeam's earnings per share (EPS) in fiscal 2025?
HeartBeam's diluted EPS was -$0.62 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did HeartBeam generate in fiscal 2025?
HeartBeam generated -$14.6M of free cash flow in fiscal 2025.
What was HeartBeam's revenue last quarter?
In its most recent reported quarter (2026 Q2), HeartBeam reported revenue of $0.
How many shares of HeartBeam are outstanding?
HeartBeam reported a weighted average of 52.8 million basic shares outstanding in 2026 Q2.
What is HeartBeam's market cap?
Based on its latest closing price, HeartBeam (BEAT) has a market capitalization of about $21.2M.
When does HeartBeam's fiscal year end?
HeartBeam's fiscal year end, as registered with the SEC, is December 31.
Where is HeartBeam headquartered?
HeartBeam lists its business address in Santa Clara, California in its SEC filings.